Fidelity Investments’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-220
Closed -$614 5623
2026
Q1
$614 Buy
+220
New +$748 ﹤0.01% 5145
2025
Q4
Sell
-63
Closed -$233 5467
2025
Q3
$233 Buy
+63
New +$159 ﹤0.01% 5144
2025
Q2
Sell
-1,950
Closed -$3.04K 5380
2025
Q1
$3.04K Sell
1,950
-18,799
-91% -$33.1K ﹤0.01% 4817
2024
Q4
$42K Sell
20,749
-5,718
-22% -$10.4K ﹤0.01% 3927
2024
Q3
$38.2K Buy
26,467
+1,806
+7% +$3.44K ﹤0.01% 3893
2024
Q2
$42.2K Buy
24,661
+440
+2% +$798 ﹤0.01% 3701
2024
Q1
$48.4K Sell
24,221
-20
-0.1% -$40 ﹤0.01% 3602
2023
Q4
$73K Buy
24,241
+18,653
+334% +$49.3K ﹤0.01% 3350
2023
Q3
$24.3K Sell
5,588
-13
-0.2% -$89 ﹤0.01% 3707
2023
Q2
$46.2K Buy
5,601
+15
+0.3% +$148 ﹤0.01% 3469
2023
Q1
$68.7K Hold
5,586
﹤0.01% 3321
2022
Q4
$54.9K Hold
5,586
﹤0.01% 3412
2022
Q3
$72K Sell
5,586
-431
-7% -$6.45K ﹤0.01% 3358
2022
Q2
$76K Buy
6,017
+414
+7% +$6.13K ﹤0.01% 3411
2022
Q1
$114K Buy
+5,603
New +$153K ﹤0.01% 3405
2021
Q3
Hold
0
4555
2021
Q2
Hold
0
4437
2013
Q4
Sell
-335,045
Closed -$35.3M 2640
2013
Q3
$35.3M Buy
335,045
+96,734
+41% +$11.9M 0.01% 1444
2013
Q2
$30.7M Buy
+238,311
New +$35.1M 0.01% 1472

Other funds holding FBIO

Fidelity Investments's FBIO Position: Q2 2026 in Review

Fidelity Investments sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 220 shares — an estimated $614 sold.

Fidelity Investments first reported a position in FBIO in Q2 2013 and held it in 17 quarters. The position peaked at $35.3M in Q3 2013. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Fidelity Investments reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 220 Fortress Biotech shares in Q2 2026, an estimated $614.
  • Fidelity Investments first reported a position in Fortress Biotech in Q2 2013 and held it in 17 quarters.
  • Fidelity Investments's Fortress Biotech position peaked at $35.3M in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.